Accelerating Access to Optimal Child-Friendly Antiretroviral Formulations for Children Living with HIV
Quantification and Budgeting for Rapid and Sustainable Access to New Pediatric Antiretroviral Therapies
Towards a Transformative and Disruptive Action to Accelerate Efforts to End HIV in Children, Adolescents, and Families